Oxford-McGill-Zurich Partnership

In May 2019, four new pilot projects and one workshop were granted by the partnership. Pilot projects explore the feasibility of a new (high-risk) approach or research path and have duration of one year. The objective of a pilot project is to generate preliminary data that will be used to support research grant applications.

The following projects will start this summer:

  • Konrad Weber, Dept of Neurology, USZ, and Maria Isabel Leite, Nuffield Department of Clinical Neurosciences, University of Oxford: “Oxford Study on vestibular evoked myogenic potentials for myasthenic disorders”.
  • Olivia Faull, Institute for Biomedical Engineering, University of Zürich and ETH Zürich, Dennis Jensen, Department of Kinesiology and Physical Education, McGill University and Kyle Pattinson, Nuffield Department of Clinical Neurosciences, University of Oxford: “Workshop on understanding the brain-body interface and its importance for physiological and psychological symptom burden”.
  • Aiman Saab, Institute of Pharmacology and Toxicology, UZH, and Alyson Fournier at the Montreal Neurological Institute: “Imaging of genetically coded cell viability sensors in EAE”.
  • Chris Pryce, Department of Psychiatry, Psychotherapy & Psychosomatics, PUK, and Naguib Mechawar, Department of Psychiatry, McGill University: “Human and mouse investigation into the influence of early-life stress on oligodendrocytes in the amygdala”.
  • Paola Picotti and William James, Sir William Dunn School of Pathology, University of Oxford: “Modulation of alpha-synuclein aggregation in iPSC derived microglia”.

The next call for research proposals is foreseen in fall 2019.

For more information on Oxford-McGill-Zurich Partnership in Neuroscience, read ZNZ News Renewed Partnership or visit the ZNZ website.